← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

NDA · New Drug Application · Sponsor: HIKMA · Approved 2023-01-30

Drug application

FDA Application #

NDA217415

Application type

New Drug Application

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HIKMA

Manufacturer

Civica, Inc.

First approval

2023-01-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown